» Articles » PMID: 39665335

Exploring the Fecal Metabolome in Infants With Cow's Milk Allergy: The Distinct Impacts of Cow's Milk Protein Tolerance Acquisition and of Synbiotic Supplementation

Overview
Date 2024 Dec 12
PMID 39665335
Authors
Affiliations
Soon will be listed here.
Abstract

Scope: Cow's milk allergy (CMA) is one of the most prevalent food allergies in early childhood, often treated via elimination diets including standard amino acid-based formula or amino acid-based formula supplemented with synbiotics (AAF or AAF-S). This work aimed to assess the effect of cow's milk (CM) tolerance acquisition and synbiotic (inulin, oligofructose, Bifidobacterium breve M-16 V) supplementation on the fecal metabolome in infants with IgE-mediated CMA.

Methods And Results: The CMA-allergic infants received AAF or AAF-S for a year during which fecal samples were collected. The samples were subjected to metabolomics analyses covering gut microbial metabolites including SCFAs, tryptophan metabolites, and bile acids (BAs). Longitudinal data analysis suggested amino acids, BAs, and branched SCFAs alterations in infants who outgrew CMA during the intervention. Synbiotic supplementation significantly modified the fecal metabolome after 6 months of intervention, including altered purine, BA, and unsaturated fatty acid levels, and increased metabolites of infant-type Bifidobacterium species: indolelactic acid and 4-hydroxyphenyllactic acid.

Conclusion: This study offers no clear conclusion on the impact of CM-tolerance acquisition on the fecal metabolome. However, our results show that 6 months of synbiotic supplementation successfully altered fecal metabolome and suggest induced bifidobacteria activity, which subsequently declined after 12 months of intervention.

Citing Articles

Exploring the Fecal Metabolome in Infants With Cow's Milk Allergy: The Distinct Impacts of Cow's Milk Protein Tolerance Acquisition and of Synbiotic Supplementation.

Zhu P, Savova M, Kindt A, Wopereis H, Belzer C, Harms A Mol Nutr Food Res. 2024; 69(1):e202400583.

PMID: 39665335 PMC: 11704826. DOI: 10.1002/mnfr.202400583.

References
1.
Ruohtula T, de Goffau M, Nieminen J, Honkanen J, Siljander H, Hamalainen A . Maturation of Gut Microbiota and Circulating Regulatory T Cells and Development of IgE Sensitization in Early Life. Front Immunol. 2019; 10:2494. PMC: 6842923. DOI: 10.3389/fimmu.2019.02494. View

2.
Beloborodova N, Khodakova A, Bairamov I, Olenin A . Microbial origin of phenylcarboxylic acids in the human body. Biochemistry (Mosc). 2009; 74(12):1350-5. DOI: 10.1134/s0006297909120086. View

3.
Davis J, Totten S, Huang J, Nagshbandi S, Kirmiz N, Garrido D . Identification of Oligosaccharides in Feces of Breast-fed Infants and Their Correlation with the Gut Microbial Community. Mol Cell Proteomics. 2016; 15(9):2987-3002. PMC: 5013312. DOI: 10.1074/mcp.M116.060665. View

4.
Wang H, Mei L, Deng Y, Liu Y, Wei X, Liu M . Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis. Nutrition. 2019; 62:63-73. DOI: 10.1016/j.nut.2018.11.018. View

5.
Burks A, Harthoorn L, Van Ampting M, Oude Nijhuis M, Langford J, Wopereis H . Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants. Pediatr Allergy Immunol. 2015; 26(4):316-22. DOI: 10.1111/pai.12390. View